Health and Healthcare
FDA Ignites Ocular Inflammation Treatment Dextenza in Most Recent Approval
Published:
Last Updated:
Ocular Therapeutix, Inc. (NASDAQ: OCUL) shares jumped on Friday after the firm announced that the U.S. Food and Drug Administration (FDA) approved a Supplemental New Drug Application (sNDA) for Dextenza to include, as an additional indication, the treatment of ocular inflammation following ophthalmic surgery.
With the approval of the sNDA, Dextenza is now approved for the treatment of both ocular inflammation and pain following ophthalmic surgery.
The approval of this sNDA was supported by three Phase 3 vehicle-controlled trials. In all three trials, Dextenza had, at a statistically significant level, a higher proportion of patients than the vehicle group who were pain-free on post-operative on Day 8. On post-operative Day 14, in two of the three studies, Dextenza had a higher proportion of patients than the vehicle group, at a statistically significant level, than those who had an absence of anterior chamber cells.
Originally, Dextenza received FDA approval in November 2018 for the treatment of ocular pain following ophthalmic surgery.
Antony Mattessich, the company’s president and CEO, commented:
We could not be more excited about both the approval and its earlier-than-expected timing. With our C-Code and pass-through payment status effective on July 1, the expanded indication gives us tremendous momentum as we approach our commercial launch.
Shares of Ocular Therapeutix were last seen up about 7% at $4.41, with a 52-week range of $2.35 to $7.79. The consensus analyst price target is $9.67.
The Average American Is Losing Their Savings Every Day (Sponsor)
If you’re like many Americans and keep your money ‘safe’ in a checking or savings account, think again. The average yield on a savings account is a paltry .4% today, and inflation is much higher. Checking accounts are even worse.
Every day you don’t move to a high-yield savings account that beats inflation, you lose more and more value.
But there is good news. To win qualified customers, some accounts are paying 9-10x this national average. That’s an incredible way to keep your money safe, and get paid at the same time. Our top pick for high yield savings accounts includes other one time cash bonuses, and is FDIC insured.
Click here to see how much more you could be earning on your savings today. It takes just a few minutes and your money could be working for you.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
